Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMO.IR dose-ranging placebo-controlled trial for maintenance of alcohol abstinence
2011-000575-14Phase 2Completed
- Sponsor
- D&A Pharma
- Start
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of sodium oxybate in alcohol dependence (5 arms), sponsored by D&A Pharma. Primary endpoint: Percentage of Days Abstinent. Started Jan 2012; status: completed.
02
Drugs
sodium oxybate
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on 2011-000575-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000575-14.